Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma (Q57141720)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

title

Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Nirmish Singla

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Ahmet M Aydin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Vandana Panwar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Solomon L Woldu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Yuval Freifeld

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Christopher G Wood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Jose A Karam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Alon Z Weizer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Jay D Raman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Mesut Remzi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Andrea Haitel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Karim Bensalah

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Arthur I Sagalowsky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Aditya Bagrodia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Payal Kapur

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Vitaly Margulis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Laura-Maria Krabbe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Nathalie Rioux-Leclercq

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Christian Bolenz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Yair Lotan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

language of work or name

English

0 references

publication date

7 May 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

page(s)

343.e1-343.e8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

26 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

The Polycomb complex PRC2 and its mark in life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

EZH2: an epigenetic gatekeeper promoting lymphomagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Interplay between the cancer genome and epigenome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

EZH2: biology, disease, and structure-based drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Roles of the EZH2 histone methyltransferase in cancer epigenetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Clinicopathological and prognostic significance of EZH2 expression in upper urinary tract carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Increased expression of EZH2, a polycomb group protein, in bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Urothelial carcinoma of the bladder and the upper tract: disparate twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Ureteral and Multifocal Tumours Have Worse Prognosis than Renal Pelvic Tumours in Urothelial Carcinoma of the Upper Urinary Tract Treated by Nephroureterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Ureteral tumours showing a worse prognosis than renal pelvis tumours may be attributed to ureteral tumours more likely to have hydronephrosis and less likely to have haematuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Targeting the cancer epigenome for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2018.04.004

10.1016/J.UROLONC.2018.04.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29748098%20AND%20SRC:MED&resulttype=core&format=json